Product Details
Product Name:
Indirubin Derivative E804 |
CAS No.:
854171-35-0 |
Purity:
98.75% |
Supply Ability:
10g |
Release date:
2024/11/07 |
Product Introduction
Bioactivity
名稱 | Indirubin Derivative E804 |
描述 | Indirubin Derivative E804 is a potent insulin-like growth factor type 1 receptor (IGF1R) inhibitor with potential antitumor activity. |
體外活性 | Indirubin Derivative E804 is a water-soluble derivative that effectively inhibits insulin-like growth factor 1 receptor (IGF1R) with an IC50 of 0.65 μM. In addition, Indirubin Derivative E804 also inhibits CDK2/CycE with an EC50 of 0.23 μM. [1] |
存儲條件 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 100 mg/mL (273.69 mM), Sonication is recommended.
|
關(guān)鍵字 | Indirubin Derivative E-804 | Indirubin Derivative E804 | Indirubin Derivative E 804 |
相關(guān)產(chǎn)品 | Insulin (human) | Urolithin C | I-OMe-Tyrphostin AG 538 | Picropodophyllin | Ceritinib | Brigatinib | GSK1904529A | HNMPA | Tyrphostin AG 538 | PD173074 | ALK-IN-1 | Linsitinib |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:244021-67-8
$1980.00 / 50mg
-
CAS:331467-03-9
$297.00 / 5mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$0.00/20MG |
VIP3Y
|
Changsha Staherb Natural Ingredients Co., Ltd.
|
2022-09-01 |
|
$45.00/5mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-05 |